-
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Wasiak, S., Dzobo, K. E., Rakai, B. D., Kaiser, Y., Versloot, M., Bahjat, M., Stotz, S. C., Fu, L., Sweeney, M., Johansson, J. O., Wong, N. C. W., Stroes, E. S. G., Kroon, J. & Kulikowski, E., 1 Dec 2020, In: Clinical epigenetics. 12, 1, 166.Research output: Contribution to journal › Article* › Academic › peer-review
-
Targeting epigenetics as atherosclerosis treatment: an updated view
Neele, A. E., Willemsen, L., Chen, H.-J., Dzobo, K. E. & de Winther, M. P. J., 1 Dec 2020, In: Current opinion in lipidology. 31, 6, p. 324-330 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Surmounting the endothelial barrier for delivery of drugs and imaging tracers
Schnitzler, J. G., Dzobo, K. E., Nurmohamed, N. S., Stroes, E. S. G. & Kroon, J., Dec 2020, In: Atherosclerosis. 315, p. 93-101 9 p.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
